105 related articles for article (PubMed ID: 10944356)
1. A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry: characterization and crystallization.
Gigant B; Barbey-Martin C; Bizebard T; Fleury D; Daniels R; Skehel JJ; Knossow M
Acta Crystallogr D Biol Crystallogr; 2000 Aug; 56(Pt 8):1067-9. PubMed ID: 10944356
[TBL] [Abstract][Full Text] [Related]
2. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
[TBL] [Abstract][Full Text] [Related]
3. Antigen distortion allows influenza virus to escape neutralization.
Fleury D; Wharton SA; Skehel JJ; Knossow M; Bizebard T
Nat Struct Biol; 1998 Feb; 5(2):119-23. PubMed ID: 9461077
[TBL] [Abstract][Full Text] [Related]
4. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
[TBL] [Abstract][Full Text] [Related]
5. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
Williams JA; Gui L; Hom N; Mileant A; Lee KK
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
[TBL] [Abstract][Full Text] [Related]
6. Structural evidence for recognition of a single epitope by two distinct antibodies.
Fleury D; Daniels RS; Skehel JJ; Knossow M; Bizebard T
Proteins; 2000 Sep; 40(4):572-8. PubMed ID: 10899782
[TBL] [Abstract][Full Text] [Related]
7. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA
Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
[TBL] [Abstract][Full Text] [Related]
9. Influenza hemagglutinin membrane anchor.
Benton DJ; Nans A; Calder LJ; Turner J; Neu U; Lin YP; Ketelaars E; Kallewaard NL; Corti D; Lanzavecchia A; Gamblin SJ; Rosenthal PB; Skehel JJ
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10112-10117. PubMed ID: 30224494
[TBL] [Abstract][Full Text] [Related]
10. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin.
Xu R; Krause JC; McBride R; Paulson JC; Crowe JE; Wilson IA
Nat Struct Mol Biol; 2013 Mar; 20(3):363-70. PubMed ID: 23396351
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment specific for an influenza virus haemagglutinin and of an escape mutant of that haemagglutinin.
Bizebard T; Mauguen Y; Petek F; Rigolet P; Skehel JJ; Knossow M
J Mol Biol; 1990 Dec; 216(3):513-4. PubMed ID: 2258927
[TBL] [Abstract][Full Text] [Related]
12. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of an idiotype-anti-idiotype Fab complex.
Ban N; Escobar C; Garcia R; Hasel K; Day J; Greenwood A; McPherson A
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1604-8. PubMed ID: 8127852
[TBL] [Abstract][Full Text] [Related]
14. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
Otterstrom JJ; Brandenburg B; Koldijk MH; Juraszek J; Tang C; Mashaghi S; Kwaks T; Goudsmit J; Vogels R; Friesen RH; van Oijen AM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5143-8. PubMed ID: 25404330
[TBL] [Abstract][Full Text] [Related]
15. CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface.
Liu Y; Pan J; Jenni S; Raymond DD; Caradonna T; Do KT; Schmidt AG; Harrison SC; Grigorieff N
J Mol Biol; 2017 Jun; 429(12):1829-1839. PubMed ID: 28506635
[TBL] [Abstract][Full Text] [Related]
16. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
18. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
Edwards MJ; Dimmock NJ
J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
Smith TJ; Chase ES; Schmidt TJ; Olson NH; Baker TS
Nature; 1996 Sep; 383(6598):350-4. PubMed ID: 8848050
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary X-ray analysis of an anti-staphylococcal nuclease-staphylococcal nuclease complex and of a second anti-staphylococcal nuclease antibody.
Chang CY; Whitaker PB; Tabernero L; Einspahr H; Workman L; Benjamin DC; Sheriff S
J Mol Biol; 1994 May; 239(1):154-7. PubMed ID: 8196044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
